tiprankstipranks
Trending News
More News >
Basilea Pharmaceutica (CH:BSLN)
:BSLN
Switzerland Market

Basilea Pharmaceutica (BSLN) Technical Analysis

Compare
7 Followers

Summary of all the Indicators

Overall Consensus
Sell
6Bullish
5Neutral
11Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Strong Sell
3Bullish
0Neutral
9Bearish
Basilea Pharmaceutica’s (BSLN) Moving Averages Convergence Divergence (MACD) indicator is -0.47, suggesting Basilea Pharmaceutica is a Buy.
Basilea Pharmaceutica’s (BSLN) 20-Day exponential moving average is 54.55, while Basilea Pharmaceutica’s (BSLN) share price is CHF52, making it a Sell.
Basilea Pharmaceutica’s (BSLN) 50-Day exponential moving average is 54.20, while Basilea Pharmaceutica’s (BSLN) share price is CHF52, making it a Sell.

Basilea Pharmaceutica (BSLN) Pivot Points

Mar 07, 2026, 10:31 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
50.80
51.60
52.70
53.50
54.60
55.40
56.50
Fibonacci
51.60
52.33
52.77
53.50
54.23
54.67
55.40
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Basilea Pharmaceutica (BSLN) Moving Averages

Mar 07, 2026, 10:31 AM
Period
Simple
Exponential
MA5
53.94Sell
53.57Sell
MA10
53.86Sell
54.03Sell
MA20
55.20Sell
54.55Sell
MA50
55.04Sell
54.20Sell
MA100
51.80Buy
52.62Sell
MA200
50.41Buy
50.58Buy
Basilea Pharmaceutica’s (BSLN) 10-Day exponential moving average is 54.03, while Basilea Pharmaceutica’s (BSLN) share price is CHF52, making it a Sell.
Basilea Pharmaceutica’s (BSLN) 100-Day exponential moving average is 52.62, while Basilea Pharmaceutica’s (BSLN) share price is CHF52, making it a Sell.
Basilea Pharmaceutica’s (BSLN) stock price is CHF52 and Basilea Pharmaceutica’s (BSLN) 50-day simple moving average is 55.04, creating a Sell signal.
Basilea Pharmaceutica’s (BSLN) stock price is CHF52 and Basilea Pharmaceutica’s (BSLN) 100-day simple moving average is 51.80, creating a Buy signal.
Basilea Pharmaceutica’s (BSLN) stock price is CHF52 and Basilea Pharmaceutica’s (BSLN) 200-day simple moving average is 50.41, creating a Buy signal.

Basilea Pharmaceutica (BSLN) Technical Indicators

Mar 07, 2026, 10:31 AM
Name
Value
Implied Action
RSI (14)
40.53
Neutral
STOCH (9,6)
37.21
Neutral
STOCHRSI (14)
23.92
Neutral
MACD (12,26)
-0.47
Buy
ADX (14)
13.34
Buy
Williams %R
-85.96
Buy
CCI (14)
-84.50
Neutral
ATR (14)
1.74
-
Ultimate Oscillator
52.75
Neutral
ROC
-7.89
Sell
Basilea Pharmaceutica’s (BSLN) Relative Strength Index (RSI) is 40.53, creating a Neutral signal.
Basilea Pharmaceutica’s (BSLN) Trend Strength Indicator (ADX) is 13.34, creating a Buy signal.
Basilea Pharmaceutica’s (BSLN) Commodity Channel Index (CCI) is -84.50, creating a Neutral signal.
Basilea Pharmaceutica’s (BSLN) Price Rate of Change (ROC) is -7.89, creating a Sell signal.

FAQ

Is BSLN a Buy, Hold, or Sell?
Based on BSLN’s technical indicators, BSLN is a Sell.
    What is BSLN’s RSI (14)?
    BSLN’s RSI (14) is 40.53, which suggests BSLN is a Neutral.
      What is BSLN’s MACD?
      BSLN’s MACD is -0.47, which suggests BSLN is a Buy.
        What is BSLN’s 5-day moving average?
        BSLN’s 5-day moving average is 53.94, which suggests BSLN is a Sell.
          What is BSLN’s 20-day moving average?
          BSLN 20-day moving average is 55.20, which suggests BSLN is a Sell.
            What is BSLN’s 50-day moving average?
            BSLN’s 50-day moving average is 55.04, which suggests BSLN is a Sell.
              What is BSLN’s 200-day moving average?
              BSLN’s 200-day moving average is 50.41, which suggests BSLN is a Buy.
                What is BSLN’s Williams % R (14)?
                BSLN’s Williams % R (14) is -85.96, which suggests BSLN is a Buy.
                  What is BSLN’s CCI (14)?
                  BSLN’s CCI (14) is -84.50, which suggests BSLN is a Neutral.
                    What is the share price of Basilea Pharmaceutica?